June 25, 2024

Addressing the Research Gap in Older Women's Health: Priorities for the White House Initiative

For decades, medical research has neglected the unique health needs of women, especially older women, leaving physicians without essential knowledge to effectively manage their health.
Late last year, the Biden administration launched the White House Initiative on Women's Health Research, promising to tackle this long-standing issue. This initiative raises a critical question: What priorities should guide efforts to improve health outcomes for older women?
Stephanie Faubion, director of the Mayo Clinic's Center for Women's Health, sharply criticized the current state of research on older women's health, describing it as woefully inadequate.
One glaring example is the study of drugs like statins, widely prescribed to older adults but predominantly tested on men, with findings extrapolated to women. Faubion emphasized the urgent need for the FDA to mandate reporting clinical trial data by sex and age, highlighting disparities in drug effectiveness between men and women.
Take, for instance, the Alzheimer's drug Leqembi, approved based on a study that showed a 27% slower cognitive decline. However, deeper analysis revealed significant sex differences, with women experiencing a 12% slowdown compared to 43% in men, raising concerns about the drug's efficacy for women.
This issue is particularly pressing as nearly two-thirds of older adults with Alzheimer's are women. Older women also face higher risks of multiple medical conditions such as heart disease, autoimmune illnesses, and osteoarthritis.
Despite these challenges, women generally outlive men by over five years in the U.S., highlighting the necessity of prioritizing older women's health.
Several key research priorities have been proposed:
Heart Disease: Addressing disparities in heart disease care between men and women, particularly concerning treatment aggressiveness and procedural biases.
Brain Health: Developing strategies to reduce cognitive decline and dementia risk in women, considering factors like hormonal changes and stress.
Mental Health: Investigating factors contributing to older women's vulnerability to anxiety and depression, including hormonal shifts and societal biases.
Cancer: Improving screening and treatment guidelines for older women, tailored to individual health statuses.
Bone Health and Frailty: Studying osteoporosis prevention and treatments among older women, and strategies to maintain mobility and independence.